IRIS
COLUCCI, Silvia Concetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.198
AS - Asia 6.053
EU - Europa 5.701
SA - Sud America 1.712
Continente sconosciuto - Info sul continente non disponibili 603
AF - Africa 402
OC - Oceania 18
Totale 31.687
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.688
SG - Singapore 2.470
IT - Italia 2.253
CN - Cina 1.435
BR - Brasile 1.306
HK - Hong Kong 707
SE - Svezia 695
RU - Federazione Russa 530
DE - Germania 482
VN - Vietnam 409
FI - Finlandia 372
UA - Ucraina 360
FR - Francia 325
GB - Regno Unito 315
CA - Canada 222
CI - Costa d'Avorio 219
IN - India 205
BD - Bangladesh 167
AR - Argentina 124
ID - Indonesia 95
CO - Colombia 80
MX - Messico 74
IQ - Iraq 70
TR - Turchia 70
JP - Giappone 68
EC - Ecuador 56
IE - Irlanda 52
PL - Polonia 52
PK - Pakistan 51
VE - Venezuela 51
NL - Olanda 50
SA - Arabia Saudita 48
ZA - Sudafrica 45
ES - Italia 43
BE - Belgio 37
MA - Marocco 36
NI - Nicaragua 31
LT - Lituania 30
PY - Paraguay 28
UZ - Uzbekistan 28
JM - Giamaica 26
CW - ???statistics.table.value.countryCode.CW??? 25
PE - Perù 25
HN - Honduras 24
CL - Cile 23
CR - Costa Rica 23
PH - Filippine 23
SV - El Salvador 23
IL - Israele 21
IR - Iran 20
EG - Egitto 19
MY - Malesia 19
TT - Trinidad e Tobago 19
PR - Porto Rico 17
TN - Tunisia 17
AU - Australia 16
AZ - Azerbaigian 16
GT - Guatemala 16
AT - Austria 15
LB - Libano 15
TH - Thailandia 15
CZ - Repubblica Ceca 14
JO - Giordania 14
ET - Etiopia 12
GP - Guadalupe 12
KE - Kenya 12
KR - Corea 12
AE - Emirati Arabi Uniti 11
AL - Albania 9
OM - Oman 9
UY - Uruguay 9
AO - Angola 8
BO - Bolivia 8
BY - Bielorussia 8
PA - Panama 8
DZ - Algeria 7
NP - Nepal 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
EU - Europa 6
KG - Kirghizistan 6
KZ - Kazakistan 6
SY - Repubblica araba siriana 6
DK - Danimarca 5
HR - Croazia 5
MN - Mongolia 5
PS - Palestinian Territory 5
RS - Serbia 5
CH - Svizzera 4
CY - Cipro 4
GR - Grecia 4
MU - Mauritius 4
NG - Nigeria 4
SC - Seychelles 4
SI - Slovenia 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CG - Congo 3
HU - Ungheria 3
Totale 31.060
Salva come PNG Salva come JPEG
Città #
Ashburn 1.931
Fairfield 1.437
Singapore 1.347
San Jose 1.319
Woodbridge 994
Chandler 905
Jacksonville 808
Hong Kong 703
Houston 703
Cambridge 602
Milan 594
Seattle 591
Nyköping 522
Wilmington 499
Bari 484
Ann Arbor 467
Beijing 378
Council Bluffs 344
Dallas 298
New York 254
Roxbury 235
Lawrence 226
Abidjan 219
Lauterbourg 213
Nanjing 211
Rome 211
Los Angeles 206
Boardman 162
Santa Clara 155
Helsinki 148
Des Moines 147
Princeton 143
São Paulo 130
Munich 125
Ho Chi Minh City 121
Brooklyn 105
Hanoi 96
Inglewood 89
Buffalo 88
San Diego 88
London 74
Grumo Appula 70
Shenyang 63
Chicago 62
Columbus 62
Dearborn 57
Jakarta 57
Nanchang 56
Hebei 54
Montreal 53
Dublin 50
Figino 48
Jiaxing 47
Redwood City 47
Tianjin 45
Warsaw 45
Rio de Janeiro 44
Tokyo 44
Turin 44
Atlanta 43
Phoenix 43
Pune 43
Changsha 41
Baghdad 37
Guangzhou 37
Brussels 36
Orem 36
Toronto 36
Frankfurt am Main 34
Moscow 34
Belo Horizonte 33
Denver 33
Trani 33
Falkenstein 31
San Francisco 31
Paris 29
Managua 28
Turku 27
Dong Ket 26
Naples 26
North Bergen 26
The Dalles 26
Charlotte 25
Willemstad 25
Falls Church 24
Johannesburg 24
Mexico City 24
Shanghai 24
Tashkent 24
Boydton 23
Brasília 23
Chennai 23
Caracas 22
Noicattaro 22
Poplar 22
Quito 22
Boston 21
Curitiba 21
Leawood 21
Nuremberg 21
Totale 20.500
Salva come PNG Salva come JPEG
Nome #
Functions of vasopressin and oxytocin in bone mass regulation 477
Irisin prevents microgravity-induced impairment of osteoblast differentiation in vitro during the space flight CRS-14 mission 308
The myokine irisin increases cortical bone mass 267
Impairment of bone remodeling in LIGHT/TNFSF14-deficient mice 258
Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice 242
Irisin serum levels are positively correlated with bone mineral status in a population of healthy children 240
Effects of sweet cherry polyphenols on enhanced osteoclastogenesis associated with childhood obesity 234
Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: Crosstalk between the immune and bone systems 227
Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α 224
Reference Intervals (RIs) of the Bone Turnover Markers (BTMs) in Children and Adolescents: A Proposal for Effective Use 222
High Sclerostin and Dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus 214
Irisin and Bone: From Preclinical Studies to the Evaluation of Its Circulating Levels in Different Populations of Human Subjects 213
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 206
An update on the role of RANKL–RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases 206
Crosstalk Between Muscle and Bone Via the Muscle-Myokine Irisin 203
Integrated in vitro approaches to assess the bioaccessibility and bioavailability of silicon-biofortified leafy vegetables and preliminary effects on bone 202
A role of light as potential biomarker for progression of smoldering to symptomatic multiple myeloma 199
Osteogenic differentiation of mesenchymal stem cells from dental bud: Role of integrins and cadherins 192
Aortic valvular interstitial cells apoptosis and calcification is mediated by TNF-related apoptosis-inducing ligand 192
Bone Fragility in Turner Syndrome: Mechanisms and Prevention Strategies 190
Mechanisms involved in childhood obesity-related bone fragility 190
Monoclonal antibodies for treating osteoporosis 188
Deletion of the Transcription Factor PGC-1α in Mice Negatively Regulates Bone Mass 187
Irisin levels correlate with bone mineral density in soccer players 184
High irisin levels are associated with better glycemic control and bone health in children with Type 1 diabetes 176
Sclerostin stimulates angiogenesis in human endothelial cells 175
Alteration of activity and survival of osteoblasts obtained from human periodontitis patients: role of TRAIL 174
TRAIL effect on osteoclast formation in physiological and pathological conditions 174
Alteration of the osteogenic properties of bone marrow stromal cells from multiple myeloma bone disease patients 171
Adhesion properties and integrin expression of cultured human osteoclast-like cells 171
Irisin and musculoskeletal health 171
Human myeloma cell lines induce osteoblast down-regulation of CD99 which is involved in osteoblast formation and activity 170
Irisin Prevents Disuse-Induced Osteocyte Apoptosis 168
Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures. 166
Alendronate reduces adhesion of human osteoclast-like cells to bone and bone protein-coated surfaces 165
FNDC5/Irisin System in Neuroinflammation and Neurodegenerative Diseases: Update and Novel Perspective 165
Alteration of bone remodeling in multiple myeloma bone disease: role of sclerostin 164
Bone Marrow Oxytocin Mediates the Anabolic Action of Estrogen on the Skeleton 164
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 164
LIGHT/TNFSF14 Promotes Osteolytic Bone Metastases in Non-small Cell Lung Cancer Patients 161
THE ROLE OF LIGHT ON BONE REMODELING 157
A new titanium biofunctionalized interface based on poly(pyrrole-3-acetic acid) coating: proliferation of osteoblast-like cells and future perspectives 156
Alterazione delle capacità osteogeniche in cellule stromali ottenute da midollo osseo di pazienti affetti da mieloma multiplo 154
Alterazione del rimodellamento osseo in soggetti in età pediatrica affetti da deficit di 21-idrossilasi (21-OHD): ruolo di DKK1 154
Adesione e proliferazione di osteoblasti su acido polipirrol-3-acetico elettrosintetizzato su titanio e TiAlV per lo sviluppo di substrati bioattivi per applicazioni in campo ortopedico. 153
The effects of bone pâté on human osteoblasts cell cultures 153
Osteogenic differentiation of dental follicle stem cells. 152
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment 149
Irisin Treatment Prevents Isoproterenol-Induced Cardiac Fibrosis in Mice 147
T cells support osteoclastogenesis in an in vitro model derived from psoritic arthritis 147
L-Carnitine Fumarate and Isovaleryl-L-Carnitine Fumarate Accelerate the Recovery of Bone Volume/Total Volume Ratio after Experimetally Induced Osteoporosis in Pregnant Mice 147
Bone matrix protein and Minaralization 145
Sclerostin is overexpressed by plasma cells from multiple myeloma patients 144
Soluble Decoy Receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 143
Binding of osteopontin to the osteoclast integrin alpha v beta 3 142
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice 142
Mechanisms of enhanced osteoclastogenesis in Alkaptonuria 141
Biological characteristics of dental stem cells for tissue engineering. 141
Histopathology of spontaneous brain herniations into the middle ear 140
Rat hindlimb unloading by tail suspension reduces osteoblast differentiation, induces IL-6 secretion, and increases bone resorption in ex-vivo cultures 139
Alterazione del potenziale osteogenico in osteoblasti ottenuti da soggetti affetti da malattia parodontale: ruolo dei recettori apoptotici per TRAIL 138
CELLULAR MECHANISMS OF BONE REGENERATION: ROLE OF WNT-1 IN BONE-MUSCLE INTERACTION DURING PHYSICAL ACTIVITY 138
Another link between bone and immune system: LIGHT 137
Osteotropic Cancers: From Primary Tumor to Bone 137
The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis 137
T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction 137
Altered osteogenic properties of bone marrow stromal cells from multiple myeloma patients 137
A novel interplay between irisin and PTH: from basic studies to clinical evidence in hyperparathyroidism 136
Mechanisms of Altered Bone Remodeling in Multiple Myeloma 136
Oxytocin is an Anabolic Bone Hormone 135
Normal and osteoporotic human osteoblast behaviour after 1,25-dihydroxy-vitamin D(3) stimulation 135
FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis 135
Neridronate and human osteoblasts in normal, osteoporotic and osteoarthritic subjects 135
Myokines and Osteokines in the Pathogenesis of Muscle and Bone Diseases 135
Irisin Modulates Inflammatory, Angiogenic, and Osteogenic Factors during Fracture Healing 134
T cells support osteoclastogenesis in an in vitro model derived from human periodontitis patients 134
Impact of 10-day bed rest on serum levels of irisin and markers of musculoskeletal metabolism 133
Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement 133
Shedding “LIGHT” on the Link between Bone and Fat in Obese Children and Adolescents 133
The OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 132
Irisin Serum Levels in Metabolic Syndrome Patients Treated with Three Different Diets: A Post-Hoc Analysis from a Randomized Controlled Clinical Trial 132
TRAIL is involved in human osteoclast apoptosis 132
Irisin for care and prevention of osteoporosis 132
Osteoblast Apoptosis in Periodontal Disease: Role of TNF-related apoptosis-inducing ligand 132
Regulated production of the pituitary hormone oxytocin from murine and human osteoblasts 131
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss 131
Response of human osteoblasts to polymethylmetacrylate In vitro 130
Activation of alphav beta3 integrin on human osteoclast-like cells stimulates adhesion and migration in response to osteopontin 130
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation 129
High expression of TRAIL by osteoblastic differentiated dental pulp stem cells affects myeloma cell viability 129
Irisin for care and prevention of osteoporosis 129
T cells support the in vitro formation of osteoclasts in multiple myeloma-bone disease: the role of OPG/TRAIL interaction 128
Myeloma cells suppress osteoblasts through sclerostin secretion 128
Human osteoclast-like cells from giant cell tumors of bone: a new tool for investigating bone resorption and osteoclast biology 127
The Role of LIGHT in Multiple Myeloma-Bone Disease 127
Improvement of Cortical Bone Mineral Density associated with physical exercise is exerted through the myokine Irisin. 126
In vitro osteoclastogenesis and T-cell RANKL expression in multiple myeloma-bone disease at diagnosis and in the setting of frontline treatment 126
The osteoclast cytoskeleton 126
LIGHT INVOLVEMENT IN MULTIPLE MYELOMA-OSTEOLYTIC BONE DISEASE 126
Effects of calcium-phosphate-based materials on proliferation and alkaline phosphatase activity of newborn rat periosteal cells in vitro 124
Totale 16.392
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.703
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.367 0 0 0 0 69 118 70 94 197 112 291 416
2022/20232.651 425 254 143 194 345 334 39 298 483 17 45 74
2023/2024978 98 188 44 54 78 251 23 23 22 45 45 107
2024/20254.253 196 58 332 142 99 418 460 342 161 268 580 1.197
2025/20269.985 1.318 450 775 1.044 962 525 1.033 378 1.035 840 273 1.352
2026/20273.149 379 479 789 1.453 49 0 0 0 0 0 0 0
Totale 31.687